Effectiveness of a Novel omega-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
Mozaffarian D, Maki KC, Bays HE, Aguilera F, Gould G, Hegele RA, Moriarty PM, Robinson JG, Shi P, Tur JF, Lapointe JF, Aziz S, Lemieux P; TRILOGY (Study of CaPre in Lowering Very High Triglycerides) investigators.
Mozaffarian D, et al.
JAMA Netw Open. 2022 Jan 4;5(1):e2141898. doi: 10.1001/jamanetworkopen.2021.41898.
JAMA Netw Open. 2022.
PMID: 34989797
Free PMC article.
Clinical Trial.
OBJECTIVE: To determine the phase 3 efficacy and safety of a naturally derived krill oil with eicosapentaenoic acid and docosahexaenoic acid as both phospholipid esters (PLs) and free fatty acids (FFAs) (omega-3-PL/FFA [CaPre]), measured by fasting TG levels and oth …
OBJECTIVE: To determine the phase 3 efficacy and safety of a naturally derived krill oil with eicosapentaenoic acid and docosa …